Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry

Journal of the American College of Cardiology

Volumn 30, Issue 5, 1997, Pages 1165-1171

  Kasper, Wolfgang ^a   Konstantinides, Stavros ^b   Geibel, Annette ^b   Olschewski, Manfred ^b   Heinrich, Fritz ^c   Grosser, Klaus D ^d   Rauber, Klaus ^e   Iversen, Stein ^f   Redecker, Matthias ^b   Kienast, Joachim ^g  

^a ST JOSEFS HOSPITAL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Krankenhaus   (Germany)

^d Städtische Krankenanstalten   (Germany)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

^f Herzzentrum Frankfurt   (Germany)

^g Universitatsklinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMBOLECTOMY; FEMALE; HEART CATHETERIZATION; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESUSCITATION; TREATMENT OUTCOME;

EID: 0030779281     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00319-7     Document Type: Article

References (22)

1. Goldhaber SZ, Visani L. The International Cooperative Pulmonary Embolism Registry. Chest. 108:1995;302-304.
2. Hull RD, Raskob GE, Coates G, Panju AA, Gill GJ. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med. 149:1989;2549-2555.
3. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet. 340:1992;873-876.
4. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism randomised trial assessing right-ventricular function and pulmonary perfusion . Lancet. 341:1993;507-511.
5. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA. 236:1976;1477-1480.
6. Hall RJC, Sutton GC, Kerr IH. Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J. 39:1977;1128-1134.
7. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 77:1997;346-349.
8. Kelley MA, Carson JL, Pelevsky HI, Schwartz S. Diagnosing pulmonary embolism new facts and strategies . Ann Intern Med. 114:1991;300-306.
9. Konstantinides S, Geibel A, Kasper W, et al. Predictors of in-hospital mortality in patients with acute massive pulmonary embolism results of the Management and Prognosis of Pulmonary Embolism Registry [abstract] . Circulation. 94:(Suppl I):1996;I-572.
10. Konstantinides S, Kasper W, Kienast J, et al. Favorable effect of thrombolytic treatment on the clinical course of hemodynamically stable patients with acute massive pulmonary embolism [abstract]. Circulation. 94:(Suppl I):1996;I-572.
11. Kasper W, Meinertz T, Henkel B, et al. Echocardiographic findings in patients with proven pulmonary embolism. Am Heart J. 112:1986;1284-1290.
12. Kasper W, Geibel A, Tiede N, et al. Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J. 70:1993;352-356.
13. Bailar JC III, Mosteller F. Medical Uses of Statistics. 2nd ed. 1992;293-310 NEJM Books, Waltham (MA).
14. The Urokinase in Pulmonary Embolism Trial a national cooperative study . Circulation. 47:(Suppl II):1973;II-1-108.
15. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 326:1992;1240-1245.
16. Gulba DC, Schmid C, Borst HG, et al. Medical compared with surgical treatment for massive pulmonary embolism. Lancet. 343:1994;576-577.
17. Cannon CP, Goldhaber SZ. Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol. 78:1996;1149-1151.
18. Stein PD, Hull RD, Raskob G. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Ann Intern Med. 121:1994;313-317.
19. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism pathophysiologic factors, detection, and therapeutic implications . Am Heart J. 130:1995;1276-1282.
20. Moser KM. Venous thromboembolism. Am Rev Resp Dis. 131:1990;235-249.
21. Goldhaber SZ. Pulmonary embolism thrombolysis a clarion call for international collaboration . J Am Coll Cardiol. 19:1992;246-247.
22. Verstraete M. Thrombolytic treatment. BMJ. 311:1995;582-583.